| Old Articles: <Older 6421-6430 Newer> |
|---|
 |
BusinessWeek
June 24, 2010
Bliss & Decker |
Ending the Silence of Generic Drugmakers The FTC says drugmakers are paying generic rivals not to compete.   |
The Motley Fool
June 24, 2010
Luke Timmerman |
Amylin Cuts 60 Jobs The pharmaceutical company says research is still a priority. |
Fast Company
July 2010
Stephanie Schomer |
A Look at the Inflatable Hospitals of Doctors Without Borders A logistics manager worked with Doctors Without Borders' R&D teams to transform inflatable tent structures into fully functioning hospitals. |
Chemistry World
June 23, 2010
Sarah Houlton |
A smaller future for big pharma? Cutting the amount spent on medicines may be an easy way for governments to help balance the books in the short term, but in the long run it will impact the ability to discover new medicines. |
The Motley Fool
June 23, 2010
Brian Orelli |
Duo of Diabetes Drug Deals Make J&J Better Licensing deals add to Johnson & Johnson's diabetes franchise. |
The Motley Fool
June 23, 2010
Brian Orelli |
A Novel Drug Technology Worth Watching Regulus signs up another microRNA partner. |
The Motley Fool
June 23, 2010
Kris Eddy |
Drugmakers Finally Recognize the Next Big Opportunity Drug companies seem to be increasing efforts to address female health problems. |
The Motley Fool
June 22, 2010
Luke Timmerman |
Regulus Therapeutics Forms $750M MicroRNA Deal With Sanofi The company has found its second big ally from Big Pharma. |
The Motley Fool
June 22, 2010
Dave Mock |
A Big Upgrade for DepoMed This bullish call comes from more than just one analyst. |
The Motley Fool
June 22, 2010
Ryan McBride |
John Glaser, Boston's Top Hospital Geek, Talks About Obama's Health IT Plan and Getting Booted from Catholic School An interview with John Glaser and a look at the health IT landscape in the U.S. |
| <Older 6421-6430 Newer> Return to current articles. |
